Bradbury Daniel's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Feb 3, 2023
- Accession no.
- 0001447362-23-000013
- Filed
- Feb 3, 2023
- Trade date
- Feb 1-2, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 12 non-derivative transactions. Open-market sales total $687.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bradbury DanielCIK 0001236397 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2023 | Common Stock | SSaleDisposed | −7,445 | $26.98F2 | −$200,866.1 | 192,094 | Indirect | |
| Feb 1, 2023 | Common Stock | SSaleDisposed | −2,481 | $26.98F2 | −$66,937.38 | 95,299 | Indirect | |
| Feb 1, 2023 | Common Stock | SSaleDisposed | −2,482 | $26.98F2 | −$66,964.36 | 95,323 | Indirect | |
| Feb 1, 2023 | Common Stock | SSaleDisposed | −4,451 | $27.51F6 | −$122,447.01 | 187,643 | Indirect | |
| Feb 1, 2023 | Common Stock | SSaleDisposed | −1,484 | $27.51F6 | −$40,824.84 | 93,815 | Indirect | |
| Feb 1, 2023 | Common Stock | SSaleDisposed | −1,483 | $27.51F6 | −$40,797.33 | 93,840 | Indirect | |
| Feb 2, 2023 | Common Stock | SSaleDisposed | −2,684 | $28.55F7 | −$76,628.2 | 184,959 | Indirect | |
| Feb 2, 2023 | Common Stock | SSaleDisposed | −895 | $28.55F7 | −$25,552.25 | 92,920 | Indirect | |
| Feb 2, 2023 | Common Stock | SSaleDisposed | −895 | $28.55F7 | −$25,552.25 | 92,945 | Indirect | |
| Feb 2, 2023 | Common Stock | SSaleDisposed | −420 | $29.12F8 | −$12,230.4 | 184,539 | Indirect | |
| Feb 2, 2023 | Common Stock | SSaleDisposed | −140 | $29.12F8 | −$4,076.8 | 92,780 | Indirect | |
| Feb 2, 2023 | Common Stock | SSaleDisposed | −140 | $29.12F8 | −$4,076.8 | 92,805 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $26.320 to $27.315, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $27.320 to $27.905, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $28.100 to $29.035, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $29.105 to $29.145, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.